Henri Doods

Neuroscience · Life Sciences

38h-index6.3kcitations127works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuropeptides and Animal Physiology(51), Receptor Mechanisms and Signaling(41), Pain Mechanisms and Treatments(22), Migraine and Headache Studies(15), Coagulation, Bradykinin, Polyphosphates, and Angioedema(12)

Publications127 total

Neuropeptide Y receptors in GtoPdb v.2025.3
IUPHAR/BPS Guide to Pharmacology CITE·2025Open Access
Neuropeptide Y receptors in GtoPdb v.2023.1
IUPHAR/BPS Guide to Pharmacology CITE·2023· 1 citedOpen Access
Triple-tyrosine kinase inhibition by BIBF1000 attenuates airway and pulmonary arterial remodeling following chronic allergen challenges in mice
European journal of medical research·2023· 2 citedOpen Access
Kinin B1 receptor blockade attenuates hepatic fibrosis and portal hypertension in chronic liver diseases in mice
Journal of Translational Medicine·2022· 10 citedOpen Access
Reversal of pulmonary arterial hypertension and neointimal formation by kinin B1 receptor blockade
Respiratory Research·2021· 15 citedOpen Access
Inhibition of microsomal prostaglandin E synthase-1 ameliorates acute lung injury in mice
Journal of Translational Medicine·2021· 19 citedOpen Access
Inhibition of human microsomal PGE2 synthase‐1 reduces seizure‐induced increases of P‐glycoprotein expression and activity at the blood‐brain barrier
The FASEB Journal·2019· 33 citedOpen Access
Neuropeptide Y receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
IUPHAR/BPS Guide to Pharmacology CITE·2019· 2 citedOpen Access
(407) Preclinical Evaluation of Human Somatostatin Receptor 4 (hSSTR4) Agonist CNTX-0290 for Mixed Pain Conditions
Journal of Pain·2019
Contents
Translational research·2018Open Access
Triple-tyrosine kinase inhibition attenuates pulmonary arterial hypertension and neointimal formation
Translational research·2018· 12 cited
Standard analgesics reverse burrowing deficits in a rat CCI model of neuropathic pain, but not in models of type 1 and type 2 diabetes-induced neuropathic pain
Behavioural Brain Research·2018· 24 citedOpen Access
Behavioural, morphological and electrophysiological assessment of the effects of type 2 diabetes mellitus on large and small nerve fibres in Zucker diabetic fatty, Zucker lean and Wistar rats
European Journal of Pain·2018· 27 cited
Anti-inflammatory activity of the bradykinin B<sub>1</sub>R antagonist in a model of LPS-induced lung inflammation in cynomolgus monkey
2016
Kinin B1 receptor blockade and ACE inhibition attenuate cardiac postinfarction remodeling and heart failure in rats
Toxicology and Applied Pharmacology·2016· 11 cited
Duloxetine and 8-OH-DPAT, but not fluoxetine, reduce depression-like behaviour in an animal model of chronic neuropathic pain
Neuroscience Letters·2016· 32 cited
Kinin B1 receptor antagonist BI113823 reduces allergen-induced airway inflammation and mucus secretion in mice
Pharmacological Research·2015· 27 cited
Pharmacological characterization of intraplantar Complete Freund’s Adjuvant-induced burrowing deficits
Behavioural Brain Research·2015· 32 cited
Kinin B1 Receptor Inhibition With BI113823 Reduces Inflammatory Response, Mitigates Organ Injury, and Improves Survival Among Rats With Severe Sepsis
The Journal of Infectious Diseases·2015· 35 citedOpen Access
Kinin B1 Receptor Antagonist BI113823 Reduces Acute Lung Injury*
Critical Care Medicine·2015· 34 cited
page 1 of 7Next →

Frequent Co-authors

Michael Entzeroth(12), K Rudolf(12), H. Wieland(12), Wolfgang Eberlein(11), Wolfhard Engel(8), Wolfgang Wienen(6), Rémi Quirion(4), Kirsten Arndt(4), Klaus‐Dieter Willim(4), Annette G. Beck‐Sickinger(3), Gerhard Hallermayer(3), Dongmei Wu(3), W. Engel(3), Rolf‐Detlef Treede(3), Angelo Ceci(3), Peter King(3), Yvan Dumont(3), Anton Pekcec(3), Klaus D. Willim(2), Kerstin Roeska(2)